Tetraoxane–Pyrimidine Nitrile Hybrids as Dual Stage Antimalarials

Oliveira R, Guedes RC, Meireles P, Albuquerque IS, Gonçalves LM, Pires E, Bronze MR, Gut J, Rosenthal PJ, Prudêncio M, Moreira R, O’Neill PM
,
et al
No abstract available
Keywords:

3207 Medical Microbiology

,

32 Biomedical and Clinical Sciences

,

3202 Clinical Sciences

,

Malaria

,

Orphan Drug

,

Rare Diseases

,

Biodefense

,

Infectious Diseases

,

Vector-Borne Diseases

,

Emerging Infectious Diseases

,

Antimicrobial Resistance

,

5.1 Pharmaceuticals

,

Animals

,

Antimalarials

,

Cell Line

,

Cysteine Endopeptidases

,

Cysteine Proteinase Inhibitors

,

Humans

,

Malaria

,

Mice, Inbred C57BL

,

Molecular Docking Simulation

,

Nitriles

,

Oxidative Stress

,

Peptidomimetics

,

Plasmodium berghei

,

Plasmodium falciparum

,

Pyrimidines

,

Structure-Activity Relationship

,

Tetraoxanes